HIV/HCV coinfection: Comorbidity and clinical implications

Research output: Contribution to journalReview articlepeer-review

Abstract

Approximately 33% of human immunodeficiency virus (HIV)-infected patients are coinfected with hepatitis C virus (HCV). Because antiretroviral therapy has become more effective and has prolonged life expectancy in HIV-infected patients, liver disease has emerged as a major cause of morbidity and mortality in those patients dually infected with HCV. HIV adversely affects all stages in the natural course of HCV infection, leading to increased viral persistence after acute infection, higher levels of viremia, and accelerated progression of cirrhosis and end-stage liver disease. The effect of HCV on the course of HIV infection is unclear, aside from the increased risk of hepatotoxicity in HIV/HCV-coinfected persons taking antiretroviral therapy. This article reviews current knowledge on the epidemiology and clinical course of HCV in HIV-infected patients.

Original languageEnglish (US)
Pages (from-to)S352-S355
JournalAdvanced Studies in Medicine
Volume5
Issue number4 C
StatePublished - Apr 1 2005

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'HIV/HCV coinfection: Comorbidity and clinical implications'. Together they form a unique fingerprint.

Cite this